Empiric use of standard triple therapy in Helicobacter pylori eradication does not require readjustment in the clarithromycin resistance cut-off point

Gut. 2024 Mar 7;73(4):708-709. doi: 10.1136/gutjnl-2023-329712.

Peter Malfertheiner^{1

2}, Francis Megraud^{3

4}, Theodore Rokkas⁵, Javier P Gisbert^{6

7}

¹ Department of Gastroenterology, Hepatology and Infectious Diseases, Otto von Guericke Universität Magdeburg, Magdeburg, Germany [email protected].
² Medical Department II, Ludwig Maximilians University Munich Faculty of Medicine, Munchen, Germany.
³ INSERM U853 UMR BaRITOn, University of Bordeaux, Bordeaux, France.
⁴ Bacteriology Laboratory, National Reference Centre for Helicobacters, Pellegrin, Bordeaux, France.
⁵ Gastroenterology, Henry Dunant Hospital Center, Athens, Greece.
⁶ Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IP), Madrid, Spain.
⁷ Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.

No abstract available

Keywords: HELICOBACTER PYLORI - TREATMENT.

Publication types